Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders

Bibliografske podrobnosti
Main Authors:	Kitley, J, Kattenbelt, M, Waters, P, Woodhall, M, George, J, Elsone, L, Jacob, A, Leite, M, Palace, J, Vincent, A
Format:	Conference item
Izdano:	2013

Podobne knjige/članki

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
od: Kitley, J, et al.
Izdano: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
od: Kitley, J, et al.
Izdano: (2013)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
od: Kitley, J, et al.
Izdano: (2012)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
od: Kitley, J, et al.
Izdano: (2013)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
od: Kitley, J, et al.
Izdano: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
od: Kitley, J, et al.
Izdano: (2014)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
od: Kitley, J, et al.
Izdano: (2014)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
od: Waters, P, et al.
Izdano: (2016)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
od: Waters, P, et al.
Izdano: (2015)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
od: Nour, M, et al.
Izdano: (2015)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
od: Kitley, J, et al.
Izdano: (2012)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
od: Kitley, J, et al.
Izdano: (2012)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
od: Leite, M, et al.
Izdano: (2009)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
od: Kitley, J, et al.
Izdano: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
od: Kitley, J, et al.
Izdano: (2014)

PREGNANCY OUTCOME IN AQUAPORIN-4 POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: A MULTI-CENTER RETROSPECTIVE COHORT STUDY
od: Nour, M, et al.
Izdano: (2014)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
od: Nour, M, et al.
Izdano: (2014)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
od: Kitley, J, et al.
Izdano: (2012)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
od: Kim, S, et al.
Izdano: (2013)

Use of mitoxantrone in neuromyelitis optica.
od: Kitley, J, et al.
Izdano: (2011)

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.
od: Waters, P, et al.
Izdano: (2008)

Seasonal pattern of variation in neuromyelitis optica relapses
od: Elsone, L, et al.
Izdano: (2012)

Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica
od: Wilson, R, et al.
Izdano: (2018)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
od: Elsone, L, et al.
Izdano: (2012)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
od: Collongues, N, et al.
Izdano: (2013)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
od: Kim, S-M, et al.
Izdano: (2016)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
od: Kitley, J, et al.
Izdano: (2011)

Gender effect on neuromyelitis optica spectrum disorder with aquaporin4-immunoglobulin G
od: Kim, S-M, et al.
Izdano: (2017)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
od: Pittock, S, et al.
Izdano: (2019)

Risk factors for immunosuppression-associated infections in aquaporin-4 antibody mediated neuromyelitis optica spectrum disorders
od: Cheng, F, et al.
Izdano: (2014)

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
od: Absoud, M, et al.
Izdano: (2014)

Interferon Beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers.
od: Palace, J, et al.
Izdano: (2010)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
od: Kitley, J, et al.
Izdano: (2012)

Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders
od: Damato, V, et al.
Izdano: (2022)

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.
od: Paul, F, et al.
Izdano: (2007)

Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
od: Elsone, L, et al.
Izdano: (2014)

Anti-aquaporin 4 antibody-positivity of Korean patients with neuromyelitis optica spectrum disorders
od: Min, J, et al.
Izdano: (2010)

Pain in neuromyelitis optica spectrum disease: a cross-sectional study in an English cohort
od: Leonard, H, et al.
Izdano: (2012)

NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT
od: George, J, et al.
Izdano: (2012)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
od: Jarius, S, et al.
Izdano: (2008)